IONIS PHARMACEUTICALS INC Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IONIS PHARMACEUTICALS INC for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 63.74 | 28,333 | 1,805,812 | 2,021 | 30.4 K to 2 K (-93.34 %) |
Jan 27 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Sell | S | 63.50 | 5,324 | 338,074 | 26,502 | 31.8 K to 26.5 K (-16.73 %) |
Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 61.68 | 40,000 | 2,467,000 | 494,391 | 534.4 K to 494.4 K (-7.49 %) |
Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 61.65 | 21,042 | 1,297,239 | 534,391 | 555.4 K to 534.4 K (-3.79 %) |
Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 60.53 | 13,958 | 844,878 | 555,433 | 569.4 K to 555.4 K (-2.45 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 0.00 | 4,371 | 0 | 7,801 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 0.00 | 47,257 | 0 | 87,885 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Payment of Exercise | F | 61.28 | 1,434 | 87,876 | 3,111 | 4.5 K to 3.1 K (-31.55 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 0.00 | 4,371 | 0 | 4,545 | 174 to 4.5 K (+2,512.07 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Payment of Exercise | F | 61.28 | 18,924 | 1,159,663 | 30,354 | 49.3 K to 30.4 K (-38.40 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 0.00 | 47,257 | 0 | 49,278 | 2 K to 49.3 K (+2,338.30 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Option Exercise | A | 0.00 | 24,228 | 0 | 24,228 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 0.00 | 15,520 | 0 | 29,641 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | A | 0.00 | 20,822 | 0 | 20,822 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Payment of Exercise | F | 61.28 | 5,488 | 336,305 | 42,508 | 48 K to 42.5 K (-11.43 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 0.00 | 15,520 | 0 | 47,996 | 32.5 K to 48 K (+47.79 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Option Exercise | M | 0.00 | 17,598 | 0 | 34,246 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Option Exercise | A | 0.00 | 22,714 | 0 | 22,714 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Payment of Exercise | F | 61.28 | 6,398 | 392,069 | 41,506 | 47.9 K to 41.5 K (-13.36 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Buy | M | 0.00 | 17,598 | 0 | 47,904 | 30.3 K to 47.9 K (+58.07 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 0.00 | 17,151 | 0 | 34,199 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | A | 0.00 | 27,129 | 0 | 27,129 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Payment of Exercise | F | 61.28 | 6,175 | 378,404 | 43,471 | 49.6 K to 43.5 K (-12.44 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 0.00 | 17,151 | 0 | 49,646 | 32.5 K to 49.6 K (+52.78 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | M | 0.00 | 34,823 | 0 | 77,243 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 0.00 | 77,447 | 0 | 77,447 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 0.00 | 66,610 | 0 | 66,610 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Payment of Exercise | F | 61.28 | 14,927 | 914,727 | 48,775 | 63.7 K to 48.8 K (-23.43 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | M | 0.00 | 34,823 | 0 | 63,702 | 28.9 K to 63.7 K (+120.58 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Option Exercise | M | 0.00 | 16,504 | 0 | 32,253 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Option Exercise | A | 0.00 | 25,868 | 0 | 25,868 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Payment of Exercise | F | 61.28 | 5,856 | 358,856 | 31,826 | 37.7 K to 31.8 K (-15.54 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Buy | M | 0.00 | 16,504 | 0 | 37,682 | 21.2 K to 37.7 K (+77.93 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 10,655 | 0 | 5,754 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Payment of Exercise | F | 61.28 | 2,741 | 167,968 | 65,378 | 68.1 K to 65.4 K (-4.02 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 10,655 | 0 | 68,119 | 57.5 K to 68.1 K (+18.54 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Option Exercise | M | 0.00 | 7,503 | 0 | 15,256 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Option Exercise | A | 0.00 | 15,753 | 0 | 15,753 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Payment of Exercise | F | 61.28 | 2,718 | 166,559 | 6,903 | 9.6 K to 6.9 K (-28.25 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Buy | M | 0.00 | 7,503 | 0 | 9,621 | 2.1 K to 9.6 K (+354.25 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Option Exercise | M | 0.00 | 8,944 | 0 | 16,944 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Option Exercise | A | 0.00 | 23,976 | 0 | 23,976 | |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Payment of Exercise | F | 61.28 | 3,216 | 197,076 | 10,835 | 14.1 K to 10.8 K (-22.89 %) |
Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Buy | M | 0.00 | 8,944 | 0 | 14,051 | 5.1 K to 14.1 K (+175.13 %) |
Jan 15 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Chief Developm ... | Sell | S | 59.50 | 141 | 8,390 | 30,306 | 30.4 K to 30.3 K (-0.46 %) |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Option Exercise | A | 56.78 | 53,945 | 3,062,997 | 53,945 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | EVP, Research | Sell | S | 55.99 | 195 | 10,918 | 5,107 | 5.3 K to 5.1 K (-3.68 %) |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | A | 56.78 | 12,000 | 681,360 | 12,000 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | EVP & General Couns ... | Option Exercise | A | 56.78 | 58,203 | 3,304,766 | 58,203 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 56.78 | 149,872 | 8,509,732 | 149,872 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | A | 56.78 | 61,041 | 3,465,908 | 61,041 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Option Exercise | A | 56.78 | 51,107 | 2,901,855 | 51,107 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Option Exercise | A | 56.78 | 54,513 | 3,095,248 | 54,513 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | A | 56.78 | 46,850 | 2,660,143 | 46,850 | |
Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | Schneider Eugene | EVP, Chf Clinical D ... | Option Exercise | A | 56.78 | 35,444 | 2,012,510 | 35,444 |